Download Citation
Article Source:
FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
Kompier LC,
Lurkin I,
van der Aa MNM,
van Rhijn BWG,
van der Kwast TH,
et al.
(2010)
FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy.
PLOS ONE 5(11): e13821.
https://doi.org/10.1371/journal.pone.0013821